Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats

European Journal of Pharmacology

Volumn 504, Issue 1-2, 2004, Pages 39-44

  Zhang, Yi ^a   Wang, Weijun ^a   Zhang, Jianjun ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

4 Butyl agarofuran (AF 5); Anxiety; Behavior; Microdialysis; Monoamine neurotransmitter; Tissue concentration

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 BUTYL ALPHA AGAROFURAN; 5 HYDROXYINDOLEACETIC ACID; ADRENALIN; AF 5; AGAROFURAN DERIVATIVE; ANXIOLYTIC AGENT; DOPAMINE; HOMOVANILLIC ACID; NEUROTRANSMITTER; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; EXPERIMENTAL TEST; EXTRACELLULAR SPACE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; MALE; MESENCEPHALON; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

EID: 6944224142     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.051     Document Type: Article

References (23)

1. J.P. Boulenger, and Y.J. Lavallee Mixed anxiety and depression: diagnostic issue J. Clin. Psychiatry 54 suppl. 1 1993 3 8
2. D.S. Charney, S.W. Woods, W.K. Goodman, and G.R. Heninger Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects Psychopharmacology (Berl.) 92 1987 14 24
3. Y. Clement, and G. Chapouthier Biological bases of anxiety Neurosci. Biobehav. Rev. 22 1998 623 633
4. L. Dazzi, F. Spiga, L. Pira, S. Ladu, G. Vacca, A. Rivano, J.D. Jentsch, and G. Biggio Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in rat prefrontal cortex by long-term treatment with antidepressant drugs J. Neurochem. 76 2001 1212 1220
5. J.F.W. Deakin, and F.G. Graeff 5-HT and mechanisms of defence J. Psychopharmacol. 5 1991 305 315
6. S.E. File The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs J. Neurosci. Methods 2 1980 219 238
7. S.E. File, and P. Seth A review of 25 years of the social interaction test Eur. J. Pharmacol. 463 2003 35 53
8. Guo, J.T., Wang, W.J., Fang, H.J., Liu, Q., Zhang, W.Y., Yin, D.L., Sun, S.J., Liu, R.W., Li, C., Liu, H.F., Wang, D.H., Novel agarofuran derivatives, their preparation, pharmaceutical composition containing them and their use as medicine. (WO: 31058. June 2, 2000). United States Patent 6486201. November 26, 2002.
9. Z.N. Jiang, H.L. Guo, Z.H. Zhu, Z.B. Li, and Y.M. Wu An epidemiological survey on use and abuse of antianxiety drugs among Beijing residents Chin. J. Neurol. Psychiatry 28 1995 12 15
10. N. Li, J.L. Zhang, and T.H. Zhou In vitro metabolic studies of the novel anti-anxietic drug AF-5 and its metabolites in human liver microsome incubation system Sin. Pharm. Sin. 36 2001 528 531
11. Q. Liu, D.H. Wang, C. Li, D. Lu, W.J. Wang, and J.Y. Guo Synthesis and CNS activities of α-agarofuran derivatives Chin. J. Med. Chem. 13 2003 125 130
12. F.F. Matos, C. Urban, and F.D. Yocca Serotonin (5-HT) release in the dorsal raphe and ventral hippocampus: raphe control of somatodendritic and terminal 5-HT release J. Neural Transm. 103 1996 173 190
13. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 2nd edition 1986 Academic Press New York
14. A. Revelli, J. Tesarik, and M. Massobrio Nongenomic effects of neurosteroids Gynecol. Endocrinol. 12 1998 61 67
15. A. Rex, C.A. Marsden, and H. Fink Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze Psychopharmacology (Berl.) 110 1993 490 496
16. A. Rex, H. Fink, and C.A. Marsden Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze Neuropharmacology 33 1994 559 565
17. R. Tao, A. Fray, S. Aspley, R. Bammer, D. Heal, and S. Auerbach Effects on serotonin in rat hypothalamus of d-fenfluramine, aminorex, phentermine and fluoxetine Eur. J. Pharmacol. 445 2002 69 81
18. M. Taraka, M. Yoshida, and H. Emoto Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies Eur. J. Pharmacol. 405 2000 397 406
19. S. Targum Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder Biol. Psychiatry 28 1990 21 34
20. S.A. Tucci, R.F. Genn, and S.E. File Mehtyllycaconitine blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of α7 receptors Neuropharmacol. 44 2003 367 373
21. L.D. Van de Kar, and M.L. Blair Forebrain pathways mediating stress-induced hormone secretion Front. Neuroendocrinol. 20 1999 1 48
22. Z.X. Wang, Y.Q. Pei, and Y.Y. Jin Clinical Psychopharmacology 1990 Beijing Medical University and Peking Union Medical College Press Beijing
23. L.K. Zhang, X.Y. Niu, and Y.W. Yu Simultaneous determination of monoamines and their main metabolites in rat brain using high performance liquid chromatography with electrochemical detection Acta Pharm. Sin. 22 1987 591 596